Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Benhur Lee
Affiliation
Icahn School of Medicine at Mount Sinai
ORCID
Career Start Year
1995
Papers
206
H Index
66
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36700640
Virology under the Microscope-a Call for Rational Discourse.
J Virol
2023
37737607
Crystal structure and solution state of the C-terminal head region of the narmovirus receptor binding protein.
mBio
2023
37610580
In Vivo Imaging of Nipah Virus Infection in Small Animal Rodent Models.
Methods Mol Biol
2023
36508860
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation.
Curr Opin Virol
2023
37142773
Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus.
Nat Microbiol
2023
37131698
An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.
bioRxiv
2023
36700653
Virology under the Microscope-a Call for Rational Discourse.
mSphere
2023
36700642
Virology under the Microscope-a Call for Rational Discourse.
mBio
2023
36700640
Virology under the Microscope-a Call for Rational Discourse.
J Virol
2023
36869692
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model.
J Infect Dis
2023
37610580
In Vivo Imaging of Nipah Virus Infection in Small Animal Rodent Models.
Methods Mol Biol
2023
37737607
Crystal structure and solution state of the C-terminal head region of the narmovirus receptor binding protein.
mBio
2023
37142773
Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus.
Nat Microbiol
2023
37131698
An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.
bioRxiv
2023
36508860
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation.
Curr Opin Virol
2023
36869692
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model.
J Infect Dis
2023
36700653
Virology under the Microscope-a Call for Rational Discourse.
mSphere
2023
36700642
Virology under the Microscope-a Call for Rational Discourse.
mBio
2023
34841388
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.
Lancet Reg Health Am
2022
36044897
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
Med
2022
35857835
Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization.
Sci Adv
2022
35781557
Classification of new morbillivirus and jeilongvirus sequences from bats sampled in Brazil and Malaysia.
Arch Virol
2022
35352979
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.
mBio
2022
36406863
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients.
iScience
2022
35915556
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection.
Gut Microbes
2022
35251918
Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2.
Acta Pharm Sin B
2022
35150620
Single-virus assay reveals membrane determinants and mechanistic features of Sendai virus binding.
Biophys J
2022
34841388
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.
Lancet Reg Health Am
2022
35107336
Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model.
mSphere
2022
35263596
The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity.
Cell Rep
2022
35263323
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.
PLoS One
2022
35352979
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.
mBio
2022
35857835
Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization.
Sci Adv
2022
35781557
Classification of new morbillivirus and jeilongvirus sequences from bats sampled in Brazil and Malaysia.
Arch Virol
2022
36406863
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients.
iScience
2022
36044897
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
Med
2022
35915556
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection.
Gut Microbes
2022
35251918
Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2.
Acta Pharm Sin B
2022
35150620
Single-virus assay reveals membrane determinants and mechanistic features of Sendai virus binding.
Biophys J
2022
35263596
The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity.
Cell Rep
2022
35263323
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.
PLoS One
2022
35107336
Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model.
mSphere
2022
33147444
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
Cell
2021
33494095
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
Nature
2021
33593976
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
mBio
2021
33903248
Fitness selection of hyperfusogenic measles virus F proteins associated with neuropathogenic phenotypes.
Proc Natl Acad Sci U S A
2021
33851150
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Res Sq
2021
33568513
Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
J Virol
2021
33513358
Dissecting ELANE neutropenia pathogenicity by human HSC gene editing.
Cell Stem Cell
2021
33444413
Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina.
PLoS Pathog
2021
1 - 50 of 412
Column Actions
Search
Recommended Authors
Hannah S Sperber
Institute for Translational HIV Research, University Hospital Essen
Career Start Year
2017
Number of shared co-authors
2
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
8
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
23
Blandine Monel
Institut Pasteur, CNRS UMR 3569
Career Start Year
2009
Number of shared co-authors
5
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
7
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
26
Jason A Wojcechowskyj
Gladstone Institutes
Career Start Year
2007
Number of shared co-authors
3
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year
2007
Number of shared co-authors
3
Charlotte A Stoneham
University of California
Career Start Year
2006
Number of shared co-authors
4
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year
2005
Number of shared co-authors
3
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
5
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year
2003
Number of shared co-authors
8
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
17
Shirit Einav
Stanford University School of Medicine
Career Start Year
2002
Number of shared co-authors
3
Nuria Izquierdo-Useros
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year
2002
Number of shared co-authors
4
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
25
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1998
Number of shared co-authors
19
Larissa B Thackray
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
7
Greg J Towers
University College London
Career Start Year
1995
Number of shared co-authors
8
Theodora Hatziioannou
The Rockefeller University
Career Start Year
1995
Number of shared co-authors
6
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
8
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
4
Robert A Davey
Boston University
Career Start Year
1991
Number of shared co-authors
8
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year
1988
Number of shared co-authors
4
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year
1987
Number of shared co-authors
10
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
11
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
20
Wendy Maury
Carver College of Medicine, University of Iowa
Career Start Year
1978
Number of shared co-authors
9
James E Crowe
Vanderbilt University Medical Center
Career Start Year
1975
Number of shared co-authors
12
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
10
row(s) 1 - 30 of 30
Collaborators
Alexander N Freiberg
University of Texas Medical Branch
Co-authored papers
23
Hector C Aguilar
Co-authored papers
22
Linda G Baum
Co-authored papers
10
Jeremy P Kamil
Louisiana State University Health Sciences Center Shreveport
Co-authored papers
10
Oscar A Negrete
Co-authored papers
8
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
8
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
7
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers
7
Elke Mühlberger
Co-authored papers
7
Mike C Wolf
Co-authored papers
7
Sina Bavari
Co-authored papers
6
Jens H Kuhn
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
6
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Co-authored papers
6
Janusz T Paweska
University of Pretoria
Co-authored papers
6
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers
6
Stephen V Su
Co-authored papers
6
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Co-authored papers
5
Ronald G Collman
University of Pennsylvania School of Medicine
Co-authored papers
5
Luis J Montaner
Wistar Institute
Co-authored papers
5
Mehul S Suthar
Co-authored papers
5
Yanjie Yi
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
5
Gary P Kobinger
University of Texas Medical Branch
Co-authored papers
5
Paul A Ramsland
College of Science, RMIT University
Co-authored papers
5
Craig B Wilen
Yale School of Medicine
Co-authored papers
4
Jean K Lim
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers
4
Matthew D Weitzman
The Children's Hospital of Philadelphia
Co-authored papers
4
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers
4
Ian Crozier
Christchurch Hospital
Co-authored papers
4
1 - 30